A man was given two years to live after a colon cancer diagnosis. Now he's healthy thanks to combination of medicine and the ...
Lipid imbalance triggered by Snail-driven epithelial–mesenchymal transition creates a cholesterol-dependent vulnerability ...
Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...
To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical ...
First-line zanidatamab plus chemotherapy leads to ‘practice-changing’ PFS and overall survival gains in a phase 3 study of ...
Amivantamab combined with FOLFOX or FOLFIRI showed a 51% overall response rate in RAS/BRAF wild-type mCRC patients, with a ...
Investigators from @hopkinskimmel (@wonjinho1, @DNSidiropoulos, @AmandaHuffPhD, @DrLizJaffee) create free atlas of ...